Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Aurora Cannabis Inc.NASDAQ: ACB

Weighted Avg Shares · Q4 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q4 FY2026 weighted avg shares of 57.47M shares rose 4.7% year over year, ahead of the +3.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at +20.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +4.7% holds above the trailing-twelve-month pace of +3.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.47M+1.4% QoQ
Last fiscal yearMar 2026
56.71M+3.3% YoY
LTMMar 2026
55.98M+3.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.7%——
1 year+3.3%——
3-year CAGR+20.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2026
56.71M CAD
Year-over-year change
+3.3%
4-year CAGR
+27.5%

Weighted Avg Shares vs competitors

How ACB compares with its peers on the latest reported figures

  • ACB's LTM Mar 2026 weighted avg shares of 55.98M shares is the 7th highest of the 11 companies compared; the peer median is 88.19M shares.
  • Its year-over-year change of +3.6% is the 9th highest of 10, against a peer median of +9.5%.
  • Over three fiscal years its annual growth of +20.7% compares with a peer median of +9.4%.
ACB Competitors Peer median
Weighted Avg Shares for ACB and competitors
Company Period LTM YoY 3-year CAGR
CGCCanopy Growth CorporationLTM Mar 2026298.22M +210.7%+300.6%
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026162.4M +1.6%+1.7%
OGIOrganigram Global Inc.LTM Mar 2026133.64M +18.7%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026124.17M +37.8%+23.4%
EDITEditas Medicine, Inc.LTM Mar 202690.28M +9.3%+8.9%
HITIHigh Tide Inc.LTM Apr 202686.1M +7.5%+9.4%
ACBAurora Cannabis Inc.LTM Mar 202655.98M +3.6%+20.7%
TKNOAlpha Teknova, Inc.LTM Mar 202653.53M +11.4%+24.0%
LFMDLifeMD, Inc.LTM Mar 202646.17M +9.5%+13.4%
BIOABioAge Labs, Inc.LTM Mar 202637.57M +7.3%+1.7%
LFCRLifecore Biomedical, Inc.LTM Mar 202637.34M —+5.7%
Peer median (excluding ACB) 88.19M+9.5%+9.4%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.